The Healthcare Sales & Marketing Network(R): Sales & Marketing News, Information and Networking for Medical Devices, Pharmaceuticals and Biotechnology.
Sales & Marketing News, Information and Networking for Medical Devices, Pharmaceuticals and Biotechnology.
Main Page: Medical News Roundups and more Medical Device and Biotech/Pharmaceutical News Medical Meetings and Conventions Calendar Message Boards for Medical Sales and Marketing Professionals, Distributors and Independent Sales Reps in Devices, Biopharmaceuticals and Diagnostics Medical Device Companies, Biotech/Pharmaceutical Companies, Distributors and Independent Sales Reps Members sections: News Roundups, News Archives, SuperSearch, Directory of Medical Sales and Marketing Professionals
Healthcare Sales & Marketing Network celebrates twelve years serving the medical device, biopharmaceutical and diagnostics community!
 
  Click for a printer-friendly version of this news story.    Click to email this news story to a friend or colleague.
Healthcare Sales & Marketing Network: HSMN NewsFeed  


News Release:  March 19, 2010

CNS Response Announces Thompson Board Resignation

ALISO VIEJO, CA--(HSMN NewsFeed) - CNS Response, Inc. (OTC.BB:CNSO ) has announced that Governor Tommy Thompson has resigned from its Board of Directors, and has agreed to become Chairman of its Advisory Board.

ADVERTISEMENT
Thompson said that the resignation was for personal reasons, adding, "I have nothing but the highest respect for the management and Board of CNS Response, and look forward to helping them advance this important medical technology."

About CNS Response

Today, most physicians are able to base treatment on objective test data, such as EKGs, MRIs, blood tests, etc. Broadly speaking, such advances have not yet come to those physicians practicing psychiatry.

CNS Response has developed a patented data-analysis capability that, with the help of a simple, non-invasive EEG, will analyze a patient's brain waves and compare the results to an extensive patient outcomes database. The process produces a rEEG® report providing a psychiatrist with guidance to personalize medication regimens for a patient, based on the patient's own brain physiology. To read more about the benefits this patented technology provides physicians, patients and insurers, please visit www.cnsresponse.com.

Safe Harbor Statement Under the Private Securities Litigation Reform Act of 1995

Except for the historical information contained herein, the matters discussed are forward-looking statements made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, as amended. These statements involve risks and uncertainties as set forth in the Company's filings with the Securities and Exchange Commission. These risks and uncertainties could cause actual results to differ materially from any forward-looking statements made herein.


Source:  CNS Response

Issuer of this News Release is solely responsible for its content.
Please address inquiries directly to the issuing company.


  Related Market Research  



Innovations in CNS: Novel therapeutics and future R&D strategies   

 
     
 << BACK Current newsfeed >> search news for 'CNS Response' >>
more 'Devices' news...
more 'Neurology' news...
more 'Personalized Medicine' news...
more 'Personnel' news...
   
  Add keyword to NewsTRACKER [Members] >>
     
    Click for a printer-friendly version of this news story.
  
Click to email this news story to a friend or colleague.
     

 

 
     

 

 

 HOME    •    NEWSFEED    •     MEETINGS & CONVENTIONS    •    FORUM    •    LINKS    •    TOP   
Copyright © 1998-2010 The Healthcare Sales & Marketing Network. All rights reserved.
The Healthcare Sales & Marketing Network is a registered trademark of Healthcare Sales & Marketing Network, LLC.
Powered by Redhat Enterprise Linux 4ES